Psyence Biomedical (PBM) Retained Earnings (2023 - 2025)
Psyence Biomedical (PBM) recorded quarterly Retained Earnings of -$1.88 in Q3 2025, up 100.0% quarter-over-quarter from -$56.4 million in Q1 2025, and down 101.84% on a YoY basis from $102.26 in Q3 2024.
Psyence Biomedical (PBM) Retained Earnings (2023 - 2025) Analysis & Trends
Psyence Biomedical's Retained Earnings history runs 3 years deep, the most recent figure standing at -$1.88 for Q3 2025.
- In Q3 2025, Retained Earnings fell 101.84% year-over-year to -$1.88; the TTM figure through Sep 2025 stood at -$1.88 (down 101.84% YoY), while the FY2025 annual figure was -$56.4 million, down 29502.34% from the prior year.
- Retained Earnings was -$1.88 for Q3 2025 at Psyence Biomedical, up from -$56.4 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $191982.0 in Q1 2024 to a low of -$56.4 million in Q1 2025.
- Historically, Retained Earnings has averaged -$12.5 million across 3 years, with a median of -$1.88 in 2025.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings jumped 103.05% in 2024, then tumbled 29502.34% in 2025.
- A 3-year view of Retained Earnings shows it stood at -$6.3 million in 2023, then surged by 100.0% to $102.26 in 2024, then slumped by 101.84% to -$1.88 in 2025.
- The last three Retained Earnings figures came in at -$1.88 (Q3 2025), -$56.4 million (Q1 2025), and $102.26 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -838.07 Mn |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 36.42 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.88 |
| Mar 31, 2025 | -56.45 Mn |
| Sep 30, 2024 | 102.26 |
| Mar 31, 2024 | 191,982.00 |
| Mar 31, 2023 | -6.30 Mn |